TY - JOUR
T1 - Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States
AU - Esler, Amy
AU - Hewitt, Amy
AU - Hall-Lande, Jennifer
AU - Pettingell, Sandra L.
AU - Houseworth, James
N1 - Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2019/6/15
Y1 - 2019/6/15
N2 - Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.
AB - Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.
KW - ASD
KW - Autism spectrum disorder
KW - Community living
KW - ID
KW - Intellectual and developmental disabilities
KW - National core indicators
KW - Psychotropic medications
UR - http://www.scopus.com/inward/record.url?scp=85060916786&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060916786&partnerID=8YFLogxK
U2 - 10.1007/s10803-019-03903-7
DO - 10.1007/s10803-019-03903-7
M3 - Article
C2 - 30706350
AN - SCOPUS:85060916786
SN - 0162-3257
VL - 49
SP - 2291
EP - 2303
JO - Journal of Autism and Developmental Disorders
JF - Journal of Autism and Developmental Disorders
IS - 6
ER -